{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:16:29Z","timestamp":1783718189563,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"DOI":"10.7759\/cureus.112420","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:07:41Z","timestamp":1783717661000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Negative Electrophoresis and Immunofixation: A Three-Case Series of Non-secretory Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Rihab","family":"Bentahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouhayla","family":"Bentahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumayma","family":"Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"El Boutahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safae","family":"Regragui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2017.053","article-title":"Non-secretory myeloma: ready for a new definition?","volume":"9","author":"Corso A","year":"2017","unstructured":"Corso A, Mangiacavalli S. Non-secretory myeloma: ready for a new definition?. Mediterr J Hematol Infect Dis. 2017, 9:e2017053. 10.4084\/MJHID.2017.053","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/mgmj.mgmj_132_25","article-title":"Non-secretory myeloma: clinical profile and diagnostic utility of immunohistochemistry and free light chain assay in a rare variant of plasma cell myeloma","volume":"12","author":"Trisal M","year":"2025","unstructured":"Trisal M, Rawat A, Mishra J, Sengar K, Mishra SK. Non-secretory myeloma: clinical profile and diagnostic utility of immunohistochemistry and free light chain assay in a rare variant of plasma cell myeloma. MGM J Med Sci. 2025, 12:306-12. 10.4103\/mgmj.mgmj_132_25","journal-title":"MGM J Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International Myeloma Working Group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass J","year":"2019","unstructured":"Hillengass J, Usmani S, Rajkumar SV, et al.. International Myeloma Working Group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019, 20:302-12. 10.1016\/S1470-2045(19)30309-2","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02614","article-title":"Second Revision of the International Staging System (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) Report within the HARMONY Project","volume":"40","author":"D'Agostino M","year":"2022","unstructured":"D'Agostino M, Cairns DA, Lahuerta JJ, et al.. Second Revision of the International Staging System (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) Report within the HARMONY Project. J Clin Oncol. 2022, 40:3406-18. 10.1200\/JCO.21.02614","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos E","year":"2021","unstructured":"Terpos E, Zamagni E, Lentzsch S, et al.. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. Lancet Oncol. 2021, 22:119-30. 10.1016\/S1470-2045(20)30559-3","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar S","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, et al.. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016, 17:328-46. 10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"key":"ref8","article-title":"Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"5","author":"Dimopoulos MA","year":"2021","unstructured":"Dimopoulos MA, Moreau P,Terpos E, et al.. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. HemaSphere. 2021, 5:528.","journal-title":"HemaSphere"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/498793-beyond-negative-electrophoresis-and-immunofixation-a-three-case-series-of-non-secretory-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:07:42Z","timestamp":1783717662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/498793-beyond-negative-electrophoresis-and-immunofixation-a-three-case-series-of-non-secretory-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.112420","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}